{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T02:01:04Z","timestamp":1766023264731,"version":"3.48.0"},"reference-count":35,"publisher":"e-Century Publishing Corporation","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Transl Res"],"DOI":"10.62347\/xzct4326","type":"journal-article","created":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T04:21:39Z","timestamp":1737519699000},"page":"480-488","source":"Crossref","is-referenced-by-count":0,"title":["Retrospective analysis of the impact of pathogen spectrum and antibiotic resistance on the treatment efficacy of respiratory tract infections from 2012 to 2022"],"prefix":"10.62347","volume":"17","author":[{"given":"Yun","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"48694","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"Jiang M, Ma L, Huang Y, Wu H, Dou J and Zhou C. Antimicrobial activities of peptide Cbf-K(16) against drug-resistant Helicobacter pylori infection in vitro and in vivo. Microb Pathog 2020; 138: 103847.","DOI":"10.1016\/j.micpath.2019.103847"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Turner DN, Edwards L, Kornienko A, Frolova LV and Rogelj S. Synergistic action of substituted indole derivatives and clinically used antibiotics against drug-resistant bacteria. Future Microbiol 2020; 15: 579-590.","DOI":"10.2217\/fmb-2019-0094"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Arya SS, Sharma MM, Rookes JE, Cahill DM and Lenka SK. Vanilla modulates the activity of antibiotics and inhibits efflux pumps in drug-resistant Pseudomonas aeruginosa. Biologia 2021; 76: 781-791.","DOI":"10.2478\/s11756-020-00617-5"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Goddard TN, Patel J, Park HB and Crawford JM. Dimeric stilbene antibiotics target the bacterial cell wall in drug-resistant Gram-positive pathogens. Biochemistry 2020; 59: 1966-1971.","DOI":"10.1021\/acs.biochem.0c00213"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Gorlenko CL, Kiselev HY, Budanova EV, Zamyatnin AA Jr and Ikryannikova LN. Plant secondary metabolites in the battle of drugs and drug-resistant bacteria: new heroes or worse clones of antibiotics? Antibiotics (Basel) 2020; 9: 170.","DOI":"10.3390\/antibiotics9040170"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Yadav K, Shivahare R, Shaham SH, Joshi P, Sharma A and Tripathi R. Repurposing of existing therapeutics to combat drug-resistant malaria. Biomed Pharmacother 2021; 136: 111275.","DOI":"10.1016\/j.biopha.2021.111275"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Alhumaid S, Al Mutair A, Al Alawi Z, Alzahrani AJ, Tobaiqy M, Alresasi AM, Bu-Shehab I, Al-Hadary I, Alhmeed N, Alismail M, Aldera AH, AlHbabi F, Al-Shammari H, Rabaan AA and Al-Omari A. Antimicrobial susceptibility of Gram-positive and Gram-negative bacteria: a 5-year retrospective analysis at a multi-hospital healthcare system in Saudi Arabia. Ann Clin Microbiol Antimicrob 2021; 20: 43.","DOI":"10.1186\/s12941-021-00450-x"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Karaman R, Jubeh B and Breijyeh Z. Resistance of Gram-positive bacteria to current antibacterial agents and overcoming approaches. Molecules 2020; 25: 2888.","DOI":"10.3390\/molecules25122888"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Sundaramoorthy NS, Shankaran P, Gopalan V and Nagarajan S. New tools to mitigate drug resistance in Enterobacteriaceae - Escherichia coli and Klebsiella pneumoniae. Crit Rev Microbiol 2023; 49: 435-454.","DOI":"10.1080\/1040841X.2022.2080525"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Effah CY, Sun T, Liu S and Wu Y. Klebsiella pneumoniae: an increasing threat to public health. Ann Clin Microbiol Antimicrob 2020; 19: 1.","DOI":"10.1186\/s12941-019-0343-8"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Chang D, Sharma L, Dela Cruz CS and Zhang D. Clinical epidemiology, risk factors, and control strategies of Klebsiella pneumoniae infection. Front Microbiol 2021; 12: 750662.","DOI":"10.3389\/fmicb.2021.750662"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Acharya Y, Bhattacharyya S, Dhanda G and Haldar J. Emerging roles of glycopeptide antibiotics: moving beyond Gram-positive bacteria. ACS Infect Dis 2022; 8: 1-28.","DOI":"10.1021\/acsinfecdis.1c00367"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Acharya Y, Dhanda G, Sarkar P and Haldar J. Pursuit of next-generation glycopeptides: a journey with vancomycin. Chem Commun (Camb) 2022; 58: 1881-1897.","DOI":"10.1039\/D1CC06635H"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Boluki E, Pourhajibagher M and Bahador A. The combination of antimicrobial photocatalysis and antimicrobial photodynamic therapy to eradicate the extensively drug-resistant colistin resistant Acinetobacter baumannii. Photodiagnosis Photodyn Ther 2020; 31: 101816.","DOI":"10.1016\/j.pdpdt.2020.101816"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Fashina B and Deng Y. Smectite, sepiolite, and palygorskite for inactivation of pyocyanin, a biotoxin produced by drug-resistant Pseudomonas aeruginosa. Micropor Mesopor Mat 2022; 331: 111668.","DOI":"10.1016\/j.micromeso.2021.111668"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Zaidan N, Hornak JP and Reynoso D. Extensively drug-resistant acinetobacter baumannii nosocomial pneumonia successfully treated with a novel antibiotic combination. Antimicrob Agents Chemother 2021; 65: e0092421.","DOI":"10.1128\/AAC.00924-21"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Huang D, Hu X, Wang C, Zhu D and Tang M. “One body and two wings” novel nanozyme combined with photothermal therapy for combat drug-resistant bacteria. J Biomater Appl 2022; 37: 474-481.","DOI":"10.1177\/08853282221092222"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Mukherjee S, Ghosh S and Haldar J. Amphiphilic cationic macromolecule potentiates tetracycline against multi-drug resistant Gram-negative bacteria. B Mater Sci 2020; 43: 311.","DOI":"10.1007\/s12034-020-02284-3"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Nasir S, Vohra MS, Gul D, Swaiba UE, Aleem M, Mehmood K and Andleeb S. Novel antibiotic combinations of diverse subclasses for effective suppression of extensively drug-resistant methicillin-resistant staphylococcus aureus (MRSA). Int J Microbiol 2020; 2020: 8831322.","DOI":"10.1155\/2020\/8831322"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Paukner S, Moran GJ, Sandrock C, File TM Jr, Vidal JE, Waites KB, Gelone SP and Yu K. A plain language summary of how lefamulin alone can be used to treat pneumonia caught outside of the hospital due to common bacterial causes, including drug-resistant bacteria. Future Microbiol 2022; 17: 397-410.","DOI":"10.2217\/fmb-2021-0276"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Lim J, Hong J, Jung Y, Ha J, Kim H, Myung H and Song M. Bactericidal effect of cecropin a fused endolysin on drug-resistant Gram-negative pathogens. J Microbiol Biotechnol 2022; 32: 816-823.","DOI":"10.4014\/jmb.2205.05009"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Ma Y, Zhang Y, Gao J, Ouyang H, He Y and Fu Z. PEGylated Ni single-atom catalysts as ultrasensitive electrochemiluminescent probes with favorable aqueous dispersibility for assaying drug-resistant pathogens. Anal Chem 2022; 94: 14047-14053.","DOI":"10.1021\/acs.analchem.2c03546"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Haeili M, Abdollahi A, Ahmadi A and Khoshbayan A. Molecular characterization of tigecycline non-susceptibility among extensively drug-resistant acinetobacter baumannii isolates of clinical origin. Chemotherapy 2021; 66: 99-106.","DOI":"10.1159\/000515100"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Bassetti M, Carnelutti A, Castaldo N and Peghin M. Important new therapies for methicillin-resistant Staphylococcus aureus. Expert Opin Pharmacother 2019; 20: 2317-2334.","DOI":"10.1080\/14656566.2019.1675637"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Reinert JP, Brown M and Ofori R. Dosing considerations for combination antistaphylococcal β-Lactam and Glyco\/lipopeptide salvage therapy for resistant Gram-positive infections: a systematic review. Ann Pharmacother 2022; 56: 193-204.","DOI":"10.1177\/10600280211021421"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Koch BCP, Muller AE, Hunfeld NGM, de Winter BCM, Ewoldt TMJ, Abdulla A and Endeman H. Therapeutic drug monitoring of antibiotics in critically ill patients: current practice and future perspectives with a focus on clinical outcome. Ther Drug Monit 2022; 44: 11-18.","DOI":"10.1097\/FTD.0000000000000942"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Karampatakis T, Tsergouli K and Behzadi P. Carbapenem-resistant Klebsiella pneumoniae: virulence factors, molecular epidemiology and latest updates in treatment options. Antibiotics (Basel) 2023; 12: 234.","DOI":"10.3390\/antibiotics12020234"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Zhang J, Yu L, Fu Y, Zhao Y, Wang Y, Zhao J, Guo Y, Li C and Zhang X. Tigecycline in combination with other antibiotics against clinical isolates of carbapenem-resistant Klebsiella pneumoniae in vitro. Ann Palliat Med 2019; 8: 622-631.","DOI":"10.21037\/apm.2019.09.11"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Yu WL, Lee NY, Wang JT, Ko WC, Ho CH and Chuang YC. Tigecycline therapy for infections caused by extended-spectrum β-lactamase-producing enterobacteriaceae in critically Ill patients. Antibiotics (Basel) 2020; 9: 231.","DOI":"10.3390\/antibiotics9050231"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Kanj SS, Bassetti M, Kiratisin P, Rodrigues C, Villegas MV, Yu Y and van Duin D. Clinical data from studies involving novel antibiotics to treat multidrug-resistant Gram-negative bacterial infections. Int J Antimicrob Agents 2022; 60: 106633.","DOI":"10.1016\/j.ijantimicag.2022.106633"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Halder U, Banerjee A, Biswas R, Sharma A, Pal S, Adhikary A and Bandopadhyay R. Production of prodigiosin by a drug-resistant Serratia rubidaea HB01 isolated from sewage. Environmental Sustainability 2020; 3: 279-287.","DOI":"10.1007\/s42398-020-00115-z"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"Ejaz H, Younas S, Qamar MU, Junaid K, Abdalla AE, Abosalif KOA, Alameen AAM, Elamir MYM, Ahmad N, Hamam SSM, Salem EHM and Bukhari SNA. Molecular epidemiology of extensively drug-resistant mcr encoded colistin-resistant bacterial strains co-expressing multifarious β-lactamases. Antibiotics (Basel) 2021; 10: 467.","DOI":"10.3390\/antibiotics10040467"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"Broger T, Koeppel L, Huerga H, Miller P, Gupta-Wright A, Blanc FX, Esmail A, Reeve BWP, Floridia M, Kerkhoff AD, Ciccacci F, Kasaro MP, Thit SS, Bastard M, Ferlazzo G, Yoon C, Van Hoving DJ, Sossen B, García JI, Cummings MJ, Wake RM, Hanson J, Cattamanchi A, Meintjes G, Maartens G, Wood R, Theron G, Dheda K, Olaru ID and Denkinger CM; TBYield Study Consortium. Diagnostic yield of urine lipoarabinomannan and sputum tuberculosis tests in people living with HIV: a systematic review and meta-analysis of individual participant data. Lancet Glob Health 2023; 11: e903-e916.","DOI":"10.2139\/ssrn.4243688"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"Durand-Reville TF, Miller AA, O’Donnell JP, Wu X, Sylvester MA, Guler S, Iyer R, Shapiro AB, Carter NM, Velez-Vega C, Moussa SH, McLeod SM, Chen A, Tanudra AM, Zhang J, Comita-Prevoir J, Romero JA, Huynh H, Ferguson AD, Horanyi PS, Mayclin SJ, Heine HS, Drusano GL, Cummings JE, Slayden RA and Tommasi RA. Rational design of a new antibiotic class for drug-resistant infections. Nature 2021; 597: 698-702.","DOI":"10.1038\/s41586-021-03899-0"},{"key":"ref34","unstructured":"Guo X, Wang L, Zhang C and Xing XH. Technology development and instrumentation of a high-throughput and automated microbial microdroplet culture system for microbial evolution and screening. Sheng Wu Gong Cheng Xue Bao 2021; 37: 991-1003."}],"container-title":["American Journal of Translational Research"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajtr\/17\/1\/ajtr0159035.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T01:56:05Z","timestamp":1766022965000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajtr\/17\/1\/ajtr0159035.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.62347\/xzct4326","relation":{},"ISSN":["1943-8141"],"issn-type":[{"type":"electronic","value":"1943-8141"}],"subject":[],"published":{"date-parts":[[2025]]}}}